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Transcription is a process by which the genetic information stored in DNA is converted into mRNA by enzymes known as RNA
polymerase. Bacteria use only one RNA polymerase to transcribe all of its genes while eukaryotes contain three RNA polymerases
to transcribe the variety of eukaryotic genes. RNA polymerase also requires other factors/proteins to produce the transcript. These
factors generally termed as transcription factors (TFs) are either associated directly with RNA polymerase or add in building
the actual transcription apparatus. TFs are the most common tools that our cells use to control gene expression. Plasmodium
falciparum is responsible for causing the most lethal form of malaria in humans. It shows most of its characteristics common to
eukaryotic transcription but it is assumed that mechanisms of transcriptional control in P. falciparum somehow diﬀer from those
of other eukaryotes. In this article we describe the studies on the main TFs such as myb protein, high mobility group protein and
ApiA2 family proteins from malaria parasite. These studies show that these TFs are slowly emerging to have deﬁned roles in the
regulation of gene expression in the parasite.
1.Introduction
Transcription is the synthesis of an RNA molecule com-
plementary to the DNA template by the action of several
enzymes. Transcription, whether prokaryotic or eukary-
otic, has three main sequential events such as initiation,
elongation, and termination [1, 2]. Initiation is the most
important step and involves the binding of RNA polymerase
todouble-strandedDNA.Elongationisthecovalentaddition
of nucleotides to the 3  end of the polynucleotide chain,
andtermination involves therecognition ofthetranscription
termination sequence and the release of RNA polymerase
[1, 2]. Transcription is the ﬁrst checkpoint in the gene
expression. The sequence of DNA that is transcribed into an
RNA molecule is called a “transcription unit” and it usually
encodes at least one gene. Transcription is considerably more
complex in eukaryotic cells as compared to bacteria. In
bacteria, all the genes are transcribed by a single RNA poly-
merase, but the eukaryotic cells contain multiple diﬀerent
RNA polymerases that transcribe various classes of genes
[3]. This enhanced complexity of eukaryotic transcription
most probably facilitates the sophisticated regulation of gene
expression needed to direct the activities of the many diﬀer-
ent cell types of multicellular organisms [4]. Three distinct
nuclear RNA polymerases are responsible for transcribing
diﬀerent classes of genes in eukaryotic cells. The ribosomal
RNAs (rRNAs) and transfer RNAs (tRNAs) are transcribed
by RNA polymerases I and III, and the protein-coding genes
are transcribed by RNA polymerase II to yield mRNAs [3, 5].
For eﬃcient transcription, RNA polymerase requires
other proteins, commonly known as transcription factors
(TFs), to produce the transcript. TFs or sequence-speciﬁc
DNA-binding factor is a protein that speciﬁcally binds to
DNA sequence and controls the stream of genetic infor-
mation from DNA to mRNA [4]. TFs along with other
proteinsinacomplexcontrolthetranscriptionbypromoting
(activator), or blocking (repressor) the recruitment of RNA
polymerase to speciﬁc genes (Figure 1). The main functions
of TFs are to bind to RNA polymerase, to bind another
TF, and to bind to cis-acting DNA sequences. TFs usually
work in groups or complexes forming multiple interactions
which allow for varying degrees of control over rates of
transcription. In eukaryotes genes are generally in an “oﬀ”
state, thus TFs mainly work to turn “on” the gene expression.2 Journal of Biomedicine and Biotechnology
While in bacteria the genes are expressed constitutively until
a TF turns it “oﬀ.” The eukaryotic genes generally contain a
promoter region upstream from the gene and/or enhancer
region upstream or downstream from the gene with some
motifs that are speciﬁcally recognized by diﬀerent types of
TFs [3]. One distinct quality of TFs is that they have DNA-
binding domains (DBDs) that give them the ability to bind
to speciﬁc promoter or enhancer sequences. The binding of
TFs triggers the other TFs to bind and this creates a complex
that ultimately facilitates binding by RNA polymerase, thus
initiating the process of transcription [3, 4].
The basal transcription complex and RNA polymerase II
bind to the core promoter of protein encoding gene which
is normally within about 50 bases upstream of the transcrip-
tion initiation site [3]. Further transcriptional regulation is
controlled by upstream control elements (UCEs), generally
present within about 200 bases upstream of the initiation
site (Figure 1). Sometimes TATA box, present in the core
promoter for Pol II, the highly conserved DNA recognition
sequence for the TATA-box-binding protein, TBP, helps in
the assembly of transcription complex at the promoter
(Figure 1). General transcription factors (GTFs) are an
important class of TFs essential for transcription (Figure 1).
Generally GTFs do not bind to DNA, but they form part of
the large transcription preinitiation complex which interacts
withRNApolymerasedirectly(Figure 1).Themostcommon
GTFs are transcription factors IIA (TFIIA), TFIIB, TFIIE,
TFIIF, and TFIIH [3, 6].
Malaria caused by the mosquito-transmitted parasite
Plasmodium falciparum is the most serious and widespread
parasiticdiseaseofhumans.Malariaisthecauseofenormous
number of deaths every year in the tropical and subtropical
areas of the world. Among four species of Plasmodium, P.
falciparum causes the most fatal form of malaria [7, 8]. Each
year, approximately two hundred and twenty-ﬁve million
people become infected with malaria and around 781,000
die as a result according to the World Health Organization’s
2010 World Malaria Report [9]. The malaria parasite has
14 chromosomes, more than 7000 genes and a four-stage
l i f ec y c l ea si tp a s s e sf r o mh u m a n st om o s q u i t o e sa n db a c k
again [7, 10]. It is very eﬃcient at evading the human
immune response. P. falciparum has a complex life cycle
that involves deﬁned morphological stages accompanied
by the stage-speciﬁc gene expression in both the human
and mosquito host, but the mechanisms of transcriptional
controlinthisparasitearenotwellknown[11].P.falciparum
contains characteristics which are common to eukaryotic
transcription [12]. But it also has exclusive patterns of gene
expression and an AT-rich genome. The genome analysis
reveals a relative paucity of transcription-associated proteins
and speciﬁc cis-regulatory motifs [11]. These observations
haveledtoreﬂectareducedrolefortheTFsintranscriptional
control in the parasite.
It has been suggested that protein levels during the life
cycle of malaria parasite are controlled through posttran-
scriptional mechanisms, thus it is possible that posttran-
scriptional regulation may play a major role in the control
of gene expression in P. falciparum. The comparisons of
mRNA and protein levels across seven major developmental
stages of the P. falciparum l i f ec y c l ew e r ec o n d u c t e d[ 13].
Even though reasonably high correlations were observed
between the transcriptome and proteome of each stage, a
considerable fraction of genes was found to display a delay
betweenthepeakabundanceofmRNAandprotein[13].The
quantitativeproteinexpressionproﬁlingduringtheschizont-
stageoftheP.falciparumdevelopmentrevealedthatextensive
posttranscriptional regulation and posttranslational mod-
iﬁcations occur in malaria parasites. These observations
further support that the posttranscriptional gene regulation
events are widespread and of presumably great biological
signiﬁcance during the intraerythrocytic development of P.
falciparum [14]. In a recent interesting study, it has been
reported that PfCLKs (cyclin-dependent kinase-like kinase)
play crucial role in malaria parasites erythrocytic replication,
presumably by participating in gene regulation through
the posttranscriptional modiﬁcation of mRNA [15]. The
rate of mRNA decay is also an essential aspect of post-
transcriptional regulation in all organisms. The half-life of
each mRNA is precisely related to its physiologic role and
thus plays an important role in determining levels of gene
expression. By using genome-wide approach to describe
mRNA decay in P. falciparum, it was observed that the
rate of mRNA decay increases severely during the asexual
intraerythrocytic developmental cycle [16].
As global eﬀorts to eradicate malaria have been unsuc-
cessful, there is a vital requirement to decipher the biology
of Plasmodium and in particular the mechanisms of gene
regulation that manage its developmental cycle, so as to
propose novel strategies to ﬁght malaria. There are only few
TFs well-characterized from P. falciparum. These are Myb1
protein, high mobility group box (HMGB) proteins, and
the Apetala2 (AP2) domain-containing proteins [17]. The
studies on these factors will be described in the following
sections.
2.MybProtein
Myb is an abbreviation derived from “myeloblastosis,” an
old name for leukemia. This family of proteins was ﬁrst
characterized in the avian myeloblastosis virus (AMV).
Myb proteins, highly conserved in eukaryotes, belong to
tryptophan cluster family and regulate gene expression by
binding to DNA [18]. Their characteristic Myb DBD of
approximately 50 residues contains three tandem repeats
(R1, R2, and R3) with three frequently spaced tryptophan
residues [18, 19]. The structure of the Myb domain is similar
to the helix-turn-helix motif of prokaryotic transcriptional
repressors and eukaryotic homeodomains. Myb proteins
bind DNA in a sequence-speciﬁc manner and regulate the
expression of genes involved in diﬀerentiation and growth
control [18].
Myb protein was recognized in the P. falciparum genome
by aligning about 200 nonredundant eukaryotic Myb pro-
teins and generating a consensus sequence analogous to the
characteristic DNA-binding domain [20]. This consensus
was used as query for the Plasmodium database which
resulted in the annotation of a 414 amino acid long open
reading frame PfMyb1 [20]. Initially, only one Myb domainJournal of Biomedicine and Biotechnology 3
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Figure 1: Representation of general transcription machinery: CA: coactivator, GTF: general transcription factor, STF: speciﬁc transcription
factor, and TBP: TATA-binding protein.
(R2) was identiﬁed in PfMyb1 but the alignment of complete
sequence of PfMyb1 (PlasmoDB number PF13 0088) with
theDBDofthreeproteins,DdMybH,DdMyb2,andDdMyb3
of Dictyostelium discoideum resulted in the recognition of
three Myb domains situated in the C-terminus of the protein
as in DdMyb2 and DdMyb3 of D. discoideum,w h e r e a s
in most of the Myb proteins DBD is located in the N-
terminus [20]. However, in place of tryptophan, PfMyb1
containsimperfectrepeatswithatyrosineoraphenylalanine.
Moreover, a critical cysteine residue, which is conserved as
the tryptophan residues was also found in R1 and R2, and
it most likely plays a role in redox regulation [20]. This
detailed computational analysis of PfMyb1 conﬁrmed that it
is a genuine Myb protein conserved in all the Plasmodium
species[20].Itwasfurtherreported thatPfMyb1is expressed
throughout all the erythrocytic developmental stages of
the parasite (rings, early and late trophozoites, as well as
early and late schizonts) [20]. The expression was analyzed
in two diﬀerent clones of P. falciparum, 3D7 and the
gametocyte-less F12 derived from 3D7, and the diﬀerence
in the mRNA proﬁle resides in a lower expression of the
Pfmyb1 transcript in the ring stage of F12 compared to
3D7, followed by a quick increase in early F12 trophozoites.
Myb-DNA-binding activity was observed with a prototype
(mim-1) and two putative Plasmodium Myb regulatory
elements, pfmap1 (MAP kinase) and pfcrk1 (cdc2-related
protein kinase) genes. These genes were originally reported
to be expressed preferentially during erythrocytic asexual
and sexual stages, respectively [21, 22]. This interaction was
conﬁrmed to be speciﬁc since it was inhibited by speciﬁc
competitors and anti-PfMyb1 antibody in band-shift assays.
During erythrocytic development, the band-shift proﬁles
were clearly diﬀerent in the 3D7 and the gametocyte-less
F12 clones, in contrast to the transcript level [20]. In a
follow-up study, the same group used long double-stranded
RNA (dsRNA) to reduce the cognate messenger and encoded
protein and reported that the parasite cultures treated with
dsRNAofPfMyb1showedgrowthinhibition [23].Asaresult
of this dsRNA inhibition, the parasite mortality occurred
during trophozoite to schizont stages of the development
suggesting that PfMyb1 is essential for parasite growth [23].
They have also shown that PfMyb1 binds to a number
of promoters such as the promoter of phosphoglycerate
kinase, calcium-dependent kinase, TATA-binding protein,
proliferating cell nuclear antigen, phosphatase, histones,
and cyclin-dependent kinase within the parasite nuclei, and
thereforedirectlyregulatesthekeygenesinvolvedincellcycle
regulation and progression [23].
3. High-Mobility-GroupBoxProtein
In eukaryotes, the high-mobility-group (HMG) box nuclear
factors are highly conserved throughout evolution. HMG
box domain is composed of around 80 amino acids folded
in three α-helices arranged in an L shape, and this domain
is involved in DNA binding [24]. HMG box proteins can
bind to non-B-type DNA structures such as cruciform and
distorted AT-rich DNA sequences in a nonsequence-speciﬁc
fashion [25]. This binding triggers DNA bending and assists
the binding of nucleoprotein complexes that in turn repress
or activate transcription [24]. HMG box domains are also
involved in a variety of protein-protein interactions. HMG
box proteins actively participate in chromatin remodeling
by increasing nucleosome sliding and accessibility of the
chromatin [25].
A P. falciparum gene encoding a typical HMG box
protein was reported [26]. The gene for PfHMG consisted of
one putative DNA-binding domain contained within a single
exon. The amino acid sequence revealed that PfHMG lacks
the acidic C-terminal domain, which is present in the HMG
of higher eukaryotes and interacts with basic proteins such
as histones [24, 26]. This domain is also absent in the HMG
of yeast and Babesia bovis [26]. The northern blot analysis of
PfHMG RNA expression showed that HMG is expressed in
all the stages of the asexual erythrocytic life cycle, with the
highest level of transcript at early schizont stages [26].
In another study, four putative P. falciparum HMG box
proteins including one previously reported were predicted
by sequence homology [26, 27]. PfHMGB1 was annotated
within chromosome 12, PfHMGB2 and PfHMGB3 on chro-
mosomes 8 and 12, and PfHMGB4 within chromosome 13,
respectively [27]. PfHMGB1 (PlasmoDB number PFL0145c)4 Journal of Biomedicine and Biotechnology
and PfHMGB2 (PlasmoDB number MAL8P1.72) are small
proteins under 100 amino acids long and contain one
characteristic HMG box domain similar to B-Box of mam-
malian HMGB1 [27, 28]. PfHMGB4 (PlasmoDB number
MAL13P1.290) encodes a 160 amino acids long protein,
but PfHMGB3 is a larger protein (2,284 amino acid), with
two HMG box domains and several additional putative
functional motifs, including one Myb domain [27]. The
sequence analysis showed that the PfHMGB1 contains 45,
23, and 18%, while PfHMGB2 shares 42, 21, and 17%
homology with Saccharomyces cerevisiae, human, and mouse
HMG box proteins, respectively [28]. The in vitro studies
performed with both the recombinant proteins showed that
they were able to interact with distorted DNA structures
and bend linear DNA. These proteins were expressed in
both asexual- and gametocyte-stage cells, and PfHMGB1 is
preferentially expressed in asexual erythrocytic stages and
PfHMGB2ingametocytes.Thesubcellularlocalizationstudy
revealed that both factors were present in the nucleus,
but PfHMGB2 was also detected in the cytoplasm of
gametocytes [27]. On the basis of diﬀerences in their levels
of expression, subcellular localizations, and capabilities for
bindingandbendingDNA,thesefactorsmostlikelyhaverole
in transcriptional regulation of Plasmodium development
[27]. In an interesting study it was reported that PfHMGB1
and PfHMGB2 are eﬀective inducers of proinﬂammatory
cytokinessuchasTNFαfrommouseperitonealmacrophages
[28]. These observations imply that secreted PfHMGB1 and
PfHMGB2 are most likely responsible for producing host
inﬂammatory immune responses associated with malaria
infection [28].
The role of HMGB2 protein in regulation of sexual stage
gene expression was evaluated by disrupting the Plasmodium
yoelii gene encoding HMGB2. It is in vivo function in
the vertebrate host the mouse and the mosquito Anopheles
stephensi was studied [29]. It has been reported that the
parasites lacking PyHMGB2 develop into gametocytes but
have severe impairment of oocyst formation [29]. It was
also shown that PyHMGB2 is not required for asexual
growth, but it is involved in controlling the genes which are
important for oocyst development in the mosquito. These
results suggest that the protein expression in sexual stages
is transcriptionally and translationally regulated, where
PyHMGB2 acts as an important regulator of sexual stage
development [29].
4.ApiA2Family
Activator protein-2 (AP-2) or Apetala2 family of tran-
scription factors constitutes a family of closely related and
evolutionarily conserved proteins that bind to the DNA
consensus sequence GCCNNNGGC and stimulate target
genetranscription.FourdiﬀerentisoformsofAP-2havebeen
identiﬁed in mammals, termed AP-2 α, β, γ,a n dδ [30, 31].
These proteins share a characteristic helix-span-helix motif
at the carboxyl terminus, which, together with a central basic
region, mediates dimerization and DNA binding. The amino
terminus contains a proline/glutamine-rich domain, which
is responsible for transcriptional activation. The general
functions of the family appear to be the cell-type-speciﬁc
stimulation of proliferation and the suppression of terminal
diﬀerentiation during embryonic development. The proteins
are able to form hetero- as well as homodimers [30, 31]. The
AP-2 factors are primarily localized in the nucleus, where
they bind to the target sequences and regulate the target gene
transcription.
Using a comparative genomic analysis, it has been
shown that the apicomplexans possess this AP2 family of
proteins which is commonly known as ApiAP2. About 20–
27 members of this ApiAP2 family are present in diﬀerent
genomes, and P. falciparum ApiAP2 gene family has 27
members, which are largely conserved across Plasmodium
species [17]. All of these are expressed throughout the four
stages of the intraerythrocytic development cycle [31, 32].
Each of these proteins contain one to four copies of the AP2
DNA-binding domain and similar to plants, these domains
in ApiAP2 proteins are also approximately 60 amino acids
long and are found in both single- and tandem-domain
arrangements [31, 32].
By using protein-binding microarrays, the DNA-binding
speciﬁcities of two ApiAP2 proteins representing diﬀerent
classes of AP2 domain architectures from P. falciparum
were demonstrated [33]. The gene with PlasmoDB number
PF14 0633encodesan813-aaprotein,whichshowshighlevel
of expression during the ring stage of development [34].
It contains a single 60 amino acids AP2 domain and an
adjoining AT-hook DNA-binding domain [33]. PF14 0633
has orthologues in all the sequenced Plasmodium genomes
and all the other sequenced apicomplexan genomes. The
other ApiAP2 gene with PlasmoDB number PFF0200c shows
high level of expression in late-stage parasites and encodes
a 1,979 amino acid protein containing two AP2 domains
in tandem. These two AP2 domains are linked with each
other by a conserved 17 amino acid sequence [33]. It was
reported that in Plasmodium spp., the orthologous tandem
AP2 domains of PFF0200c share ∼95% amino acid sequence
identity, but the individual AP2 domains of PFF0200c share
only 35% identity with each other [33]. These AP2 domains
speciﬁcally bind with unique DNA sequence motifs that are
found in the upstream regions of diﬀerent sets of genes that
are coregulated during asexual development. Interestingly,
despite the sequence deviation between ApiAP2 proteins
from distantly related Apicomplexan species (P. falciparum
andCryptosporidiumparvum),theDNA-bindingspeciﬁcities
of orthologous pairs of AP2 domains are highly conserved,
that is, TGCATGCA, although their downstream targets may
vary. This demonstrated an interaction between Plasmodium
transcriptionfactorsandtheirputativetargetsequences[33].
Using PEXEL/VTS search, it was reported that AP2
proteins do not have motifs for apicoplast targeting, mito-
chondrial transit, endoplasmic reticulum traﬃcking, trans-
membrane domains, or host cell surface targeting but the
classical lysine- and arginine-rich nuclear localization signals
were identiﬁed concluding that this protein family consisted
of TFs [33]. The Plasmodium-based global yeast two-hybrid
study suggested that ApiAP2 proteins interact with each
other and with chromatin-remodeling factors, Plasmod-
ium histone acetyltransferase GCN5 [35]. The binding toJournal of Biomedicine and Biotechnology 5
chromatin-remodeling factors may help in the recruitment
of these complexes to speciﬁc chromosomal locations and
facilitate interaction with the core transcription machinery.
The crystal structure of the DNA-bound dimer of the
AP2 domain of PF14 0633 exhibits many of the canonical
featuresofsimilarDNA-bindingdomains[36].Thestructure
of PF14 0633 shows that it dimerizes through a three
dimensional domain-swapping mechanism in which the α-
helix of one protomer is packed against the β-sheet of its
dimer mate. It was further reported that the dimerization
of the AP2 domain of PF14 0633 aligns Cys76 residues of
each monomer with one another with enough proximity to
permit the disulﬁde bond formation. It was interesting to
notethattheCys76residueisconservedinalltheorthologues
ofPF14 0633inPlasmodiumspp.,howeveritisnotconserved
in other related apicomplexan species [36]. This DNA-
induced dimerization of the AP2 domain of PF14 0633
facilitates the conformational rearrangement of the rest of
the protein or its interaction partners and this concurrently
loops out intervening DNA among pairs of binding sites
enriched in the upstream regions of a set of sporozoite-
speciﬁc genes [36].
In a recent comprehensive study, the global DNA-
binding speciﬁcities for the entire P. falciparum ApiAP2
family of DNA-binding proteins was biochemically and
computationally characterized [37]. Their results revealed
that the majority of proteins bind diverse DNA sequence
motifs and occur in functionally related sets of genes.
In a number of proteins, multiple AP2 domains within
the same ApiAP2 protein were reported to bind distinct
DNA sequences. In addition to high aﬃnity primary motif
interactions, the interactions with secondary motifs were
also observed [37]. By mapping these sequences throughout
the parasite genome, the results of this study provide a
basisfordevelopingaregulatorynetworkunderlyingparasite
development [37]. The overall studies on ApiAP2 family
of proteins in P. falciparum suggest that these proteins
are main components of gene regulation in the parasite.
Although further work is needed in order to determine
how ApiAP2 proteins function as transcriptional regulators.
But the DNA-binding sequence speciﬁcity of these proteins,
their conservation across Apicomplexa, and the extremely
consistentexpressionpatternsoftheirpredicteddownstream
targets suggest their vital function in regulating parasite
development.
During its asexual life cycle, the P. falciparum develops
into several distinct morphological forms occupies various
compartments in its human host and often faces drug
treatment. The microarray-based transcriptomic studies of
these stages reported remarkable changes in the steady-state
mRNA levels of several genes, suggesting that diﬀerential
gene expression is essential for development. It is well
establishednowthatgeneregulationinP. falciparumconsists
of a bulk transcriptional event characteristic of the majority
of genes from which diﬀerential expression of a minority of
genes is selected by a combination of pretranscriptional and
posttranscriptional mechanisms. Therefore, the modulation
of expression of the targeted genes is the outcome of the
blend of these diverse interactions.
Some of these important TFs have also been character-
ized from other protozoan parasites. For example, a member
of the HMGB was identiﬁed in Entamoeba histolytica [38]
and some Myb family members were characterized from
Trichomonas vaginalis (reviewed in [39]). The information
compiled in this paper suggests that P. falciparum indeed
contains few TFs which are responsible for the gene regula-
tion in various stages of its development. Relatively, little is
known about how the parasite uses these few TFs to globally
regulate the transcription in order to produce the proteins
essential for its development and pathogenesis. Future work
is undoubtedly required in order to solve this mystery. It
has been suggested that combinatorial gene regulation might
be the general mode of transcriptional regulation in P.
falciparum or it can be assumed that the eﬀect of various TFs
on gene expression is additive. Therefore a very useful anti-
plasmodial approach should be to target and inactivate one
or more of these TFs with drugs. This strategy will directly
or indirectly aﬀect the gene regulation and consequently the
function of several downstream genes and crucial biological
processes.Duetotheeﬀectonnumerousgenesthisapproach
will be very helpful, and it will be relatively diﬃcult for the
parasite to develop resistance to this line of drugs.
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